
Genprex Collaborators Present Positive Preclinical Data On Diabetes Gene Therapy At The ASGCT 28Th Annual Meeting
(MENAFN- PR Newswire) Novel Gene Therapy is Addressing Both Type 1 and Type 2 Diabetes AUSTIN, Texas, May 28, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX ), a clinical-stage gene therapy company …